Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: J Vasc Surg. 2023 May 2;78(3):737–744. doi: 10.1016/j.jvs.2023.04.034

Table I:

Characteristics of patients that underwent attempted endovascular intervention are shown.

Technical Failure Technical Success
Patient Characteristics N=31 N=181 p-value
Age 72.5 ± 12.7 64.7 ± 11.1 <0.001*
Male Sex 27 (87.1%) 108 (59.7%) 0.003*
Ethnicity 0.939
White 19 (61.3%) 105 (58.3%)
Black 12 (38.7%) 73 (40.6%)
OtherΔ 0 (0%) 2 (1.2%)
Current Tobacco Use or Quit <10 years ago 18 (58.1%) 62 (34.8%) 0.014*
Diabetes Mellitus (DM) 20 (66.7%) 114 (80.0%) 0.102
Hypertension (HTN) 25 (89.3%) 159 (89.8%) 0.930
Dialysis Dependent 8 (26.7%) 37 (21.1%) 0.499
Hyperlipidemia (HLD) 27 (90.0%) 155 (86.6%) 0.607
Cardiac Statusβ 0.548
SVS Grade 1 13 (41.9%) 61 (33.9%)
SVS Grade 2 1 (3.2%) 14 (7.8%)
SVS Grade 3 11 (35.5%) 79 (43.9%)
SVS Grade 4 6 (19.4%) 26 (14.4%)
Pulmonary Statusβ 0.446
SVS Grade 1 21 (70.0%) 116 (64.1%)
SVS Grade 2 1 (3.3%) 25 (13.8%)
SVS Grade 3 5 (16.7%) 25 (13.8%)
SVS Grade 4 3 (10.0%) 15 (8.3.%)
SVS WIfI 0.969
Stage 1 4 (19%) 28 (18.3%)
Stage 2 5 (23.8%) 32 (20.9%)
Stage 3 5 (23.8%) 44 (28.8%)
Stage 4 7 (33.3%) 49 (32%)
Level of Disease
Aortoiliac 3 (9.7%) 22 (12.2%) 0.693
Femoropopliteal 21 (67.7%) 139 (76.8%) 0.279
Tibial 16 (51.6%) 77 (42.5%) 0.347
Lesion Length (cm) 25.51 ± 14.95 15.35 ± 11.65 0.001*
CTO Present 31 (100%) 77 (42.5%) <0.001*

Patients with unknown characteristics were excluded from applicable denominators.

*

Statistically significant difference between groups (p<0.05).

Δ

Excluded from analysis.

β

Reported according to SVS standards.21

Some patients had disease at multiple levels.